BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nanno Y, Toyama H, Zen Y, Akita M, Ando Y, Mizumoto T, Ueda Y, Ajiki T, Okano K, Suzuki Y, Fukumoto T. Serum Elastase 1 Level as a Risk Factor for Postoperative Recurrence in Patients with Well-Differentiated Pancreatic Neuroendocrine Neoplasms. Ann Surg Oncol 2018;25:3358-64. [PMID: 30054822 DOI: 10.1245/s10434-018-6675-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Yang C, Lin R, Chen C, Yeh C, Tseng C, Huang W, Lee T, Chu C, Lin J. Accuracy of simultaneous measurement of serum biomarkers: Carbohydrate antigen 19-9, pancreatic elastase-1, amylase, and lipase for diagnosing pancreatic ductal adenocarcinoma. Journal of the Formosan Medical Association 2022. [DOI: 10.1016/j.jfma.2022.07.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Chi SF, Lai CY, Dong WT, Wang JM, Wang YY, Yang SS, Lin JT, Lee TY. Establishing the blood reference interval of pancreatic elastase-1: A prospective study. J Gastroenterol Hepatol 2021. [PMID: 34498301 DOI: 10.1111/jgh.15685] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Lee L, Ito T, Jensen RT. Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies. Expert Rev Anticancer Ther. 2019;19:1029-1050. [PMID: 31738624 DOI: 10.1080/14737140.2019.1693893] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 10.0] [Reference Citation Analysis]